Versor Investments’s Collegium Pharmaceutical COLL Stock Holding History

Versor Investments’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-31,000	Closed	-$1.44M	–	159
2025 Q4	$1.44M	Sell	31,000 -7,201	-19%	-$301K	0.22%	79
2025 Q3	$1.34M	Buy	+38,201	New	+$1.33M	0.25%	52
2025 Q2	–	Sell	-8,769	Closed	-$262K	–	738
2025 Q1	$262K	Sell	8,769 -10,813	-55%	-$330K	0.04%	600
2024 Q4	$561K	Buy	19,582 +5,200	+36%	+$172K	0.1%	337
2024 Q3	$556K	Buy	14,382 +6,014	+72%	+$214K	0.09%	380
2024 Q2	$269K	Sell	8,368 -3,900	-32%	-$135K	0.05%	559
2024 Q1	$476K	Buy	12,268 +1,689	+16%	+$59.1K	0.1%	343
2023 Q4	$326K	Buy	10,579 +1,316	+14%	+$33K	0.07%	497
2023 Q3	$207K	Buy	+9,263	New	+$211K	0.04%	582
2022 Q4	–	Sell	-11,900	Closed	-$191K	–	763
2022 Q3	$191K	Buy	+11,900	New	+$210K	0.01%	737

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Versor Investments's COLL Position: Q1 2026 in Review

Versor Investments sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 31,000 shares — an estimated $1.44M sold.

Versor Investments first reported a position in COLL in Q3 2022 and held it in 10 quarters. The position peaked at $1.44M in Q4 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

Versor Investments reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
Versor Investments sold 31,000 Collegium Pharmaceutical shares in Q1 2026, an estimated $1.44M.
Versor Investments first reported a position in Collegium Pharmaceutical in Q3 2022 and held it in 10 quarters.
Versor Investments's Collegium Pharmaceutical position peaked at $1.44M in Q4 2025.
267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.